Terms: = Breast cancer AND WT1, WAGR, 7490, ENSG00000184937, WT33, GUD, WIT-2 AND Treatment
41 results:
1. Overexpression of wt1 in all molecular subtypes of breast cancer and its impact on survival: exploring oncogenic and tumor suppressor roles of distinct wt1 isoforms.
Ben Haj Othmen H; Othman H; Khamessi O; Bettaieb I; Gara S; Kharrat M
Mol Biol Rep; 2024 Apr; 51(1):544. PubMed ID: 38642153
[TBL] [Abstract] [Full Text] [Related]
2. Comprehensive Transcriptomic Analysis of EWSR1::wt1 Targets Identifies CDK4/6 Inhibitors as an Effective Therapy for Desmoplastic Small Round Cell Tumors.
Magrath JW; Sampath SS; Flinchum DA; Hartono AB; Goldberg IN; Boehling JR; Savkovic SD; Lee SB
Cancer Res; 2024 May; 84(9):1426-1442. PubMed ID: 38588409
[TBL] [Abstract] [Full Text] [Related]
3. Frontiers of Ovarian Carcinosarcoma.
Ismail A; Choi S; Boussios S
Curr Treat Options Oncol; 2023 Dec; 24(12):1667-1682. PubMed ID: 37938504
[TBL] [Abstract] [Full Text] [Related]
4. Establishment of an experimental model of canine malignant mesothelioma organoid culture using a three-dimensional culture method.
Sato Y; Elbadawy M; Suzuki K; Tsunedomi R; Nagano H; Ishihara Y; Yamamoto H; Azakami D; Uchide T; Nabeta R; Fukushima R; Abugomaa A; Kaneda M; Yamawaki H; Shinohara Y; Usui T; Sasaki K
Biomed Pharmacother; 2023 Jun; 162():114651. PubMed ID: 37030135
[TBL] [Abstract] [Full Text] [Related]
5. Management of patients with presumed germline pathogenic variant from tumor-only genomic sequencing: A retrospective analysis at a single facility.
Kawamura M; Shirota H; Niihori T; Komine K; Takahashi M; Takahashi S; Miyauchi E; Niizuma H; Kikuchi A; Tada H; Shimada M; Kawamorita N; Kanamori M; Sugiyama I; Tsubata M; Ichikawa H; Yasuda J; Furukawa T; Aoki Y; Ishioka C
J Hum Genet; 2023 Jun; 68(6):399-408. PubMed ID: 36804482
[TBL] [Abstract] [Full Text] [Related]
6. Giant benign lymphangioendothelioma with positive expression of Wilms tumor 1: A case report.
Teixeira D; Canelhas Á; Costa M; Magalhães C; Ferreira EO; César A
J Cutan Pathol; 2022 Jan; 49(1):86-89. PubMed ID: 34423872
[TBL] [Abstract] [Full Text] [Related]
7. Proteolysis-Targeting Chimeras Enhance T Cell Bispecific Antibody-Driven T Cell Activation and Effector Function through Increased MHC Class I Antigen Presentation in cancer Cells.
Massafra V; Tundo S; Dietzig A; Ducret A; Jost C; Klein C; Kontermann RE; Knoetgen H; Steegmaier M; Romagnani A; Nagel YA
J Immunol; 2021 Jul; 207(2):493-504. PubMed ID: 34215653
[TBL] [Abstract] [Full Text] [Related]
8. New mutation in wt1 gene in a boy with an incomplete form of Denys-Drash syndrome: A CARE-compliant case report.
Akramov NR; Shavaliev RF; Osipova IV
Medicine (Baltimore); 2021 May; 100(19):e25864. PubMed ID: 34106634
[TBL] [Abstract] [Full Text] [Related]
9. Extra-abdominal ovarian cancer presenting with breast metastases at diagnosis: Case report and literature review.
Ferrari F; Ficarelli S; Forte S; Valenti G; Ardighieri L; Sartori E; Odicino F
Eur J Obstet Gynecol Reprod Biol; 2020 Dec; 255():211-221. PubMed ID: 33152565
[TBL] [Abstract] [Full Text] [Related]
10. Wilms' tumor 1 antigen immunoreactivity in epithelial ovarian cancer - diagnostic and prognostic value.
Zarychta E; Lepinay K; Szubert S; Jozwicki J; Misiak J; Brozyna AA; Kosinska-Kaczynska K; Lewandowska A; Malicka E; Makarewicz A; Rhone P; Jozwicki W
Folia Histochem Cytobiol; 2020; 58(3):198-207. PubMed ID: 32960974
[TBL] [Abstract] [Full Text] [Related]
11. Primary Peritoneal High-grade Serous Carcinoma Misinterpreted as Metastatic breast Carcinoma: A Rare Encounter in Peritoneal Fluid Cytology.
Park S; Cho EY; Oh YL; Park YH; Kim HS
Anticancer Res; 2020 May; 40(5):2933-2939. PubMed ID: 32366445
[TBL] [Abstract] [Full Text] [Related]
12. Ovarian metastases reported after adjuvant laparoscopic oophorectomies in breast cancer.
Cristian DA; Grama FA; Becheanu G; Popa I; Bratu AM; Burcoş T; Poalelungi CV; Şurlin V
Rom J Morphol Embryol; 2019; 60(3):913-920. PubMed ID: 31912104
[TBL] [Abstract] [Full Text] [Related]
13. A double-blind randomized comparative clinical trial to evaluate the safety and efficacy of dendritic cell vaccine loaded with wt1 peptides (TLP0-001) in combination with S-1 in patients with advanced pancreatic cancer refractory to standard chemotherapy.
Katsuda M; Miyazawa M; Ojima T; Katanuma A; Hakamada K; Sudo K; Asahara S; Endo I; Ueno M; Hara K; Yamada S; Fujii T; Satoi S; Ioka T; Ohira M; Akahori T; Kitano M; Nagano H; Furukawa M; Adachi T; Yamaue H
Trials; 2019 Apr; 20(1):242. PubMed ID: 31029154
[TBL] [Abstract] [Full Text] [Related]
14. Delayed IL-21 treatment preferentially expands peptide-specific CD8
Kim SH; Park SY; Lim MC; Lee ES; Lee EG; Han SE; Kim YH; Kwon BS; Choi BK
Immunotherapy; 2019 Apr; 11(6):497-513. PubMed ID: 30760061
[TBL] [Abstract] [Full Text] [Related]
15. breast metastasis two years after pelvic surgery and adjuvant chemotherapy for serous ovarian cancer.
Della Corte L; Giampaolino P; Fabozzi A; Cieri M; Zizolfi B; Morra I; Bifulco G
Gynecol Endocrinol; 2019 Mar; 35(3):211-213. PubMed ID: 30449229
[TBL] [Abstract] [Full Text] [Related]
16. Phase I/II clinical trial of a Wilms' tumor 1-targeted dendritic cell vaccination-based immunotherapy in patients with advanced cancer.
Zhang W; Lu X; Cui P; Piao C; Xiao M; Liu X; Wang Y; Wu X; Liu J; Yang L
Cancer Immunol Immunother; 2019 Jan; 68(1):121-130. PubMed ID: 30306202
[TBL] [Abstract] [Full Text] [Related]
17. Dysfunction of the wt1-MEG3 signaling promotes AML leukemogenesis via p53-dependent and -independent pathways.
Lyu Y; Lou J; Yang Y; Feng J; Hao Y; Huang S; Yin L; Xu J; Huang D; Ma B; Zou D; Wang Y; Zhang Y; Zhang B; Chen P; Yu K; Lam EW; Wang X; Liu Q; Yan J; Jin B
Leukemia; 2017 Dec; 31(12):2543-2551. PubMed ID: 28400619
[TBL] [Abstract] [Full Text] [Related]
18. wt1 expression in breast cancer disrupts the epithelial/mesenchymal balance of tumour cells and correlates with the metabolic response to docetaxel.
Artibani M; Sims AH; Slight J; Aitken S; Thornburn A; Muir M; Brunton VG; Del-Pozo J; Morrison LR; Katz E; Hastie ND; Hohenstein P
Sci Rep; 2017 Mar; 7():45255. PubMed ID: 28345629
[TBL] [Abstract] [Full Text] [Related]
19. Safety and immunogenicity of neoadjuvant treatment using wt1-immunotherapeutic in combination with standard therapy in patients with wt1-positive Stage II/III breast cancer: a randomized Phase I study.
Higgins M; Curigliano G; Dieras V; Kuemmel S; Kunz G; Fasching PA; Campone M; Bachelot T; Krivorotko P; Chan S; Ferro A; Schwartzberg L; Gillet M; De Sousa Alves PM; Wascotte V; Lehmann FF; Goss P
Breast Cancer Res Treat; 2017 Apr; 162(3):479-488. PubMed ID: 28176175
[TBL] [Abstract] [Full Text] [Related]
20. Immunotherapy of breast cancer.
Criscitiello C; Curigliano G
Prog Tumor Res; 2015; 42():30-43. PubMed ID: 26377084
[TBL] [Abstract] [Full Text] [Related]
[Next]
